Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glucocorticoid Antagonist Treatment of Alcohol Use Disorder

NCT02179749 is registered in ClinicalTrials.gov with The Scripps Research Institute as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02179749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glucocorticoid Antagonist Treatment of Alcohol Use Disorder
Lead sponsor
The Scripps Research Institute
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2014
Completion date
November 6, 2019
Enrollment
103 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol abuse, alcohol dependence, alcohol use disorders, alcoholism